Mangalam Drugs And Organics vs Nifty 50: Returns Compared

Mangalam Drugs And Organics vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Mangalam Drugs And Organics trades on the NSE under the symbol MANGALAM, and its 1M return of -2.76% compares with the Nifty 50's -5.62% over the same period.

The Mangalam Drugs And Organics vs Nifty 50 comparison matters because Mangalam Drugs And Organics is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Mangalam Drugs And Organics share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.

Also read – Mangalam Cement vs Nifty 50: Share Price Performance Compared

Click Here – Get Free Investment Predictions

Mangalam Drugs And Organics vs Nifty 50: Performance at a Glance

The table below sets out Mangalam Drugs And Organics vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 6 October 2026.

Time Frame	Mangalam Drugs And Organics Return	Nifty 50 Return	Difference
1 Month	-2.76%	-5.62%	+2.85% pp
3 Months	+4.59%	-7.55%	+12.14% pp
6 Months	-2.93%	-2.46%	-0.47% pp
1 Year	-59.67%	-10.06%	-49.61% pp
3 Years	-71.31%	+14.77%	-86.08% pp
5 Years	-79.83% (Mangalam Drugs And Organics)	+26.79% (Nifty 50)	-106.62% pp

On the Mangalam Drugs And Organics vs Nifty 50 scorecard, Mangalam Drugs And Organics has lagged the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.

Check the Univest Screener for live Mangalam Drugs And Organics and Nifty 50 data

Why the Mangalam Drugs And Organics vs Nifty 50 Gap Exists

Mangalam Drugs And Organics's stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Mangalam Drugs And Organics vs Nifty 50 return table above.

A second factor behind the Mangalam Drugs And Organics vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Mangalam Drugs And Organics's price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.

Download the Univest iOS App or Univest Android App to track Mangalam Drugs And Organics and Nifty 50 live on the go.

Mangalam Drugs And Organics vs Nifty 50: Has Mangalam Drugs And Organics Beaten the Benchmark?

Mangalam Drugs And Organics has not kept pace with the Nifty 50 over the past year, posting a return of -59.67% against the index's -10.06% over the same period.

Also read – Manorama Industries vs Nifty 50: Share Price Performance Compared

Risks of the Mangalam Drugs And Organics vs Nifty 50 Comparison

Reading too much into a Mangalam Drugs And Organics vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Mangalam Drugs And Organics carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 22.80 to Rs 73.50 also shows the kind of volatility that a single-stock investment carries relative to a broad index.

Conclusion

Mangalam Drugs And Organics vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Mangalam Drugs And Organics vs Nifty 50 record should factor in Mangalam Drugs And Organics's volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.

Has Mangalam Drugs And Organics outperformed the Nifty 50 in the last year?

Ans. No. Mangalam Drugs And Organics returned -59.67% over the past year while the Nifty 50 returned -10.06% over the same period, based on NSE closing prices to 6 October 2026.

How does Mangalam Drugs And Organics vs Nifty 50 look over 5 years?

Ans. Over five years Mangalam Drugs And Organics has returned -79.83% compared with the Nifty 50's +26.79%, so in the Mangalam Drugs And Organics vs Nifty 50 comparison the index has been ahead over this longer horizon.

What is the Mangalam Drugs And Organics share price today compared to Nifty 50?

Ans. Mangalam Drugs And Organics share price stood at Rs 29.19 on NSE, while the Nifty 50 traded at 22,555.75 based on the same closing data window.

What is the 52-week high and low of Mangalam Drugs And Organics?

Ans. Mangalam Drugs And Organics's 52-week high is Rs 73.50 and its 52-week low is Rs 22.80, based on NSE data.

Why does Mangalam Drugs And Organics show bigger price swings than the Nifty 50?

Ans. Mangalam Drugs And Organics carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Mangalam Drugs And Organics's price more sharply than the diversified index, a key reason the Mangalam Drugs And Organics vs Nifty 50 return gap varies across time frames.

Is Mangalam Drugs And Organics a good long-term investment compared to a Nifty 50 index fund?

Ans. Mangalam Drugs And Organics's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Mangalam Drugs And Organics vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.